Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study.

Cite this paper

@article{Buysschaert2014ImprovementOP, title={Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal γδ T-cell number: a prospective case-series study.}, author={Martin Buysschaert and Marie Baeck and Vanessa Preumont and Liliane Marot and Elke Hendrickx and Arne van Belle and Laure Dumoutier}, journal={The British journal of dermatology}, year={2014}, volume={171 1}, pages={155-61} }